Tetrahydrofuran → 1-(1-Ethylpropyl)-5-methyl-3-(methylsulfonyl)-2(1H)-pyrazinone

HRID 2251005Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2251005
[CH2:1]([CH:3]([N:6]1[CH:11]=[C:10]([CH3:12])[N:9]=[C:8](SC)[C:7]1=[O:15])[CH2:4][CH3:5])[CH3:2].O[O:17][S:18]([O-:20])=O.[K+].[CH2:22]1COCC1>O.C(OCC)(=O)C>[CH2:1]([CH:3]([N:6]1[CH:11]=[C:10]([CH3:12])[N:9]=[C:8]([S:18]([CH3:22])(=[O:20])=[O:17])[C:7]1=[O:15])[CH2:4][CH3:5])[CH3:2]

Komponenten

6

Edukt 3

HCID 8028TetrahydrofuranHCID 23707502Potassium hydroxy sulfiteHCID 588451711-(1-Ethylpropyl)-5-methyl-3-(methylthio)-2 (1H)-pyrazinone

Produkt 1

HCID 588451731-(1-Ethylpropyl)-5-methyl-3-(methylsulfonyl)-2(1H)-pyrazinoneAusbeute 67 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 962WaterLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Reaktionsbedingungen

Temperatur
25 °C

Versuchsvorschrift

A solution of XXXII (200 mg, 0.9 mmol) in THF (25 mL) was treated with Oxone™ (1.1 g, 1.8 mmol) portionwise as a solid at 25° C. The reaction mixture was stirred at 25° C. for 16 h and diluted with water (20 mL) and ethyl acetate (25 mL). The organic phase was dried (MgSO4), filtered, and concentrated in vacuo to give the product XXXIII (153 mg, 67%) as a yellow oil.

Aufarbeitung

  1. dry with materialThe organic phase was dried (MgSO4)
  2. filtrationfiltered
  3. concentrationconcentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-06a0d0450a4f4ebd89d0ad89041afea3
Quelldatensatz
uspto-grants-2008_01
Patentnummer
US07319100B2

Notizen zur Reaktion

Wird geladen…